UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000030493
Receipt number R000034811
Scientific Title Clinical study of infertility treatment using platelet rich plasma (PRP) to endometrium.
Date of disclosure of the study information 2017/12/25
Last modified on 2019/04/05 11:32:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical study of infertility treatment using platelet rich plasma (PRP) to endometrium.

Acronym

Clinical study of infertility treatment using platelet rich plasma (PRP) to endometrium.

Scientific Title

Clinical study of infertility treatment using platelet rich plasma (PRP) to endometrium.

Scientific Title:Acronym

Clinical study of infertility treatment using platelet rich plasma (PRP) to endometrium.

Region

Japan


Condition

Condition

Sterility

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Object to confirm the effect and the safety exerted on endometrium by inculcation in the uterus of platelet rich plasma in a patient during infertility treatment and consider the implantation rate preliminary.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Phase I,II


Assessment

Primary outcomes

Thickness of the endometrium

Key secondary outcomes

Safety
Implantation rate


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking

NO

Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

PRP Injection into uterus

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

50 years-old >

Gender

Female

Key inclusion criteria

(1) The female patient who is undergoing infertility treatment, receives in vitro fertilization (IVF) or Intracyteplasmic sperm injection (ICSI) and schedules frozen embryo transplanting (FET) of the hormone replacement cycle.
(2) The thickness of the endometrium is less than 7 mm.
(3) Obtain informed consent from patient herself.
(4) Age over 18 and under 50 (Freeze embryo until 42 years old)

Key exclusion criteria

(1) Patient with liver dysfunction
(2) Hb less than 11g/dL
(3) Platelet less than 150,000/mm3
(4) Patient using anticoagulation medicine.
(5) Pregnant
(6) Additionally something a study doctor in attendance judges to be unsuitable as a target of this research

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Osamu Tsutsumi, M.D., Ph.D.

Organization

Sanno Hospital

Division name

Reproduction Center

Zip code


Address

8-10-16 Akasaka, Minato-ku, Tokyo

TEL

+81-3-3402-3151

Email

osamut@iuhw.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Maki Kusumi, M.D., Ph.D.

Organization

Sanno Hospital

Division name

Reproduction Center

Zip code


Address

8-10-16 Akasaka, Minato-ku, Tokyo

TEL

+81-3-3402-3151

Homepage URL


Email

sannordc@gmail.com


Sponsor or person

Institute

CONCIDE(Correct health Information for Cooperative and innovative development of society)

Institute

Department

Personal name



Funding Source

Organization

Aeon International Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

山王病院(東京都)
Sanno Hospital (TOKYO)


Other administrative information

Date of disclosure of the study information

2017 Year 12 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 02 Month 14 Day

Date of IRB

2017 Year 12 Month 13 Day

Anticipated trial start date

2018 Year 02 Month 19 Day

Last follow-up date

2019 Year 01 Month 23 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 12 Month 20 Day

Last modified on

2019 Year 04 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034811


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name